ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option

ITI Mutual Fund · Sectoral/Thematic · Direct · IDCW

NAV · as of 11/09/2026

19.89

-0.30%

Key stats

Expense ratio: 0.98%
AUM: ₹262.80 Cr
Launched: 11/11/2021
Fund manager: Nilay Dalal; Animesh Singh
Portfolio turnover: 0.49%
Risk: Very High Risk
Min lump-sum: ₹5,000
Min SIP: ₹500/mo
Fresh lump-sum: Accepted
Fresh SIP: Accepted

NAV history

ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option

13/08/2026 to 11/09/2026

O - H - L -

1W+0.22%

1M-0.16%

3M+8.78%

MAX+8.69%

Top holdings

39 disclosed

1.
Sun Pharmaceuticals Industries Ltd
Healthcare
13.26%
2.
Divi's Laboratories Ltd
Healthcare
7.97%
3.
Apollo Hospitals Enterprise Ltd
Healthcare
6.05%
4.
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
5.05%
5.
Torrent Pharmaceuticals Ltd
Healthcare
4.84%
6.
Cipla Ltd
Healthcare
4.43%
7.
Dr Reddy's Laboratories Ltd
Healthcare
4.41%
8.
Laurus Labs Ltd
Healthcare
4.21%
9.
Aurobindo Pharma Ltd
Healthcare
3.84%
10.
Mankind Pharma Ltd
Healthcare
3.39%
11.
Cohance Lifesciences Ltd
Healthcare
3.04%
12.
Neuland Laboratories Ltd
Healthcare
3.03%
13.
Global Health Ltd
Healthcare
2.98%
14.
Alkem Laboratories Ltd
Healthcare
2.92%
15.
Lupin Ltd
Healthcare
2.82%
16.
Fortis Healthcare Ltd
Healthcare
2.79%
17.
Net Receivables / (Payables)
2.12%
18.
Abbott India Ltd
Healthcare
1.90%
19.
Poly Medicure Ltd
Healthcare
1.52%
20.
Ipca Laboratories Ltd
Healthcare
1.50%
21.
Aster DM Quality Care Ltd Ordinary Shares
Healthcare
1.35%
22.
Sai Life Sciences Ltd
Healthcare
1.32%
23.
Piramal Pharma Ltd
Healthcare
1.27%
24.
Shaily Engineering Plastics Ltd
Basic Materials
1.23%
25.
HealthCare Global Enterprises Ltd
Healthcare
1.21%
26.
Shilpa Medicare Ltd
Healthcare
1.15%
27.
Linde India Ltd
Basic Materials
1.10%
28.
Glenmark Pharmaceuticals Ltd
Healthcare
1.09%
29.
Rainbow Childrens Medicare Ltd
Healthcare
1.05%
30.
Biocon Ltd
Healthcare
0.95%
31.
GlaxoSmithKline Pharmaceuticals Ltd
Healthcare
0.93%
32.
Supriya Lifescience Ltd
Healthcare
0.92%
33.
Medplus Health Services Ltd
Healthcare
0.88%
34.
Zydus Lifesciences Ltd
Healthcare
0.72%
35.
Venus Pipes & Tubes Ltd
Basic Materials
0.69%
36.
Syngene International Ltd
Healthcare
0.61%
37.
Caplin Point Laboratories Ltd
Healthcare
0.54%
38.
Bharat Dynamics Ltd Ordinary Shares
Industrials
0.47%
39.
Yes Bank Ltd
Financial Services
0.46%

Sector allocation

Healthcare93.92%
Basic Materials3.03%
Unclassified2.12%
Industrials0.47%
Financial Services0.46%

Comparable peers

SBI Healthcare Opportunities IDCW Payout Direct Plan
SBI Healthcare Opportunities IDCW Payout (DP) · ₹5.40 K Cr AUM
1Y+22.46%
3Y+24.66%
-
ITI Pharma & Healthcare IDCW Reinvest Direct Plan
ITI Pharma & Healthcare IDCW Reinvest (DR) · ₹262.80 Cr AUM
1Y+12.58%
3Y+20.07%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.29%
3Y+25.53%
-
HDFC Transportation & Logistics IDCW Payout Direct Plan
HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM
1Y+9.29%
3Y+25.53%
-
HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.29%
3Y+25.53%
-

Investment objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Scheme details

Scheme code: 149271
Fund house: ITI Mutual Fund
Category: Open Ended
Type: Equity Scheme
Sub-category: Sectoral/Thematic
Plan: Direct
Return type: IDCW
ISIN (Growth): INF00XX01BP6
ISIN (Div. Reinvest): INF00XX01BQ4
Tradable on exchange: No

Kuvera page